Title : Influence of KRAS mutations on clinical outcome in patients with curatively resected stage III colon cancer treated with adjuvant chemotherapy.

Pub. Date : 2020 Mar

PMID : 32271417






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Conversely, an oxaliplatin-containing regimen should be recommended in KRAS mutated patients. Oxaliplatin KRAS proto-oncogene, GTPase Homo sapiens